Skip to main content

Flonase News

Exhalation Delivery System With Fluticasone Effective for Rhinosinusitis

FRIDAY, Jan. 26, 2024 – For patients with chronic rhinosinusitis (CRS), an exhalation delivery system that delivers fluticasone (EDS-FLU) to sinonasal areas above the inferior turbinate is...

FDA Medwatch Alert: Fluticasone Propionate Nasal Spray by Apotex Corp: Recall - Due to Potential for Small Glass Particles

ISSUE: The Fluticasone Propionate Nasal Spray 50 mcg per spray 120 Metered Sprays has been found to contain small glass particles. The glass particles could block the actuator and impact the...

Optinose Announces FDA Approval of Xhance (fluticasone propionate) Nasal Spray for the Treatment of Nasal Polyps

YARDLEY, Pa.--(BUSINESS WIRE)-- September 18, 2017 – Optinose, an ENT / Allergy specialty pharmaceutical company, announced today that the U.S. Food & Drug Administration (FDA) approved the...

FDA Approves Flonase Sensimist Allergy Relief

WARREN, N.J. 2 August 2016 – GSK Consumer Healthcare announced today that the U.S. Food and Drug Administration (FDA) has approved Flonase® Sensimist™ Allergy Relief (fluticasone furoate, 27.5 mcg sp...

FDA Approves Flonase Allergy Relief for Sale Over-the-Counter in the United States

London UK & Parsippany, US - Thursday 24 July 2014, GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase Allergy Relief...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Rhinitis

Flonase patient information at Drugs.com